This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Act against AMR: Managing UTI with the Latest Susceptibility data

28-November-2023 7:00 PM to 8:00 PM

28 Nov, 2023

Webinar

Register Now

This webinar talks about common epidemiology of UTI, its prevalence amongst women and how a proper guideline-recommended treatment plan helps combat antimicrobial resistance in patients.

 

The following topics will be discussed:
 

  • • UTI Epidemiology and etiology
  • • UTI diagnosis and guideline-recommended treatment
  • • Latest DOH Antimicrobial Resistance Surveillance Program (ARSP) data

 Speaker foto

Jeff J. Jubilado, MD

MHA, FPUA, FPCS, FICS

Present roles: Chief of Clinics & Department Chair (Surgery) -- Assumption Specialty Hospital and Medical Center ** Department Chair (Surgery) -- Pasig Doctors Medical Center. ** Department Chair (Urology) -- Marikina Valley Medical Center. ** Section Head (Urology) -- Marikina Doctors Hospital and Medical Center. ** Member American Urological Association European Association of Urology Urological Association of Asia ** Medical Affairs Manager (Urology) -- GSK Philippines

 Speaker foto

Allan Dexter M. Alejo, MD

DPDS

Medical Affairs Manager -- Anti-infectives and Dermatology, GSK Philippines.** Doctor of Medicine -- UST Faculty of Medicine and Surgery. ** Residency in Dermatology -- Skin and Cancer Foundation, Inc. ** Diplomate -- Philippine Dermatological Society.

PM-PH-ACA-WCNT-230008 November 2023

AMR, antimicrobial resistance; UTI, urinary tract infection; DOH, department of health